Engel, 63, says he lost sight in both eyes to NAION while on Ozempic. Novo Nordisk says a causal link can't be confirmed from the data.
Recap by typeshit. Full story at AOL.com.
The FDA plan would let pharmacies compound peptides like BPC-157 under enforcement discretion, even though agency scientists say safety is unproven.
A man says Mounjaro and Trulicity caused his gastroparesis, and the clip walks through who must warn patients about side effects under Indiana law.
Alicia Butterfield claims Anthem denied her Zepbound once the drug got her below morbid obesity. A Los Angeles judge stayed her case pending arbitration.
STAT
Members of Congress from both parties want the FDA to stop imports of copycat versions of Eli Lilly's experimental obesity drug, which is still in trials.
Engel, 63, says he lost sight in both eyes from NAION after starting Ozempic in 2023. His suit claims weak warnings, though a causal link hasn't been established.
Engel, 63, lost sight in both eyes to NAION and says he was never warned. Hundreds of similar suits are pending, though a causal link hasn't been proven.
Loading…